1 of 1
Story summary
- A pilot study at the University of Pittsburgh tested low-dose lithium carbonate in 80 seniors with mild cognitive impairment over two years and found a modest verbal memory improvement that did not reach statistical significance.
- The improvement was more pronounced in amyloid-positive individuals.
- The research team plans larger trials with a focus on amyloid status to better assess lithium's potential neuroprotective effects.
